Allergan (AGN) is developing a variety of products through internal programs as well as in collaboration with other companies. A few of the products it currently has under development are Cenicriviroc, Atogepant, Bimatoprost SR, Ubrogepant, Abicipar, Rapastinel, and Sarecycline.
The medical equipment maker in January signaled that muted demand for its services used in the making of therapies and vaccines will extend at least into the first half of the year, but could pick up later. The Waltham, Massachusetts-based firm said it now expects annual adjusted profit of $21.14 to $22.02 per share, compared with its previous forecast of $20.95 to $22 per share. Analysts had estimated a profit of $21.53 per share for 2024, according to LSEG data.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Gestion SAS acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust
DUBAI, United Arab Emirates, April 24, 2024--Horizon FCB Dubai Charts the Future of Advertising in Logistics with DHL’s "Delivered Yesterday" Campaign
Oklahoma authorities said Tuesday that the 10-year-old woke up on April 22 and discovered the bodies of five family members
Amersham & Chiltern Rugby Club savoured a day with British & Irish Lions and Rugby World Cup winner Jason Robinson.
First non-immunosuppressive therapy for the treatment of IgA nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT Study SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the treatment of adults with p
Korean Air is in talks over the purchase of at least 10 Boeing 777X jetliners in a potential tilt back towards its traditional U.S. supplier after placing a major order with European rival Airbus, two industry sources said. The discussions come weeks after Korean announced an order for 33 A350 jets from Airbus in what was widely seen as a breakthrough for the European planemaker into the flag carrier's Boeing-dominated wide-body fleet. The sources said discussions between Korean Air and Boeing on the 777X, an upgrade of the 777 mini-jumbo already used by South Korea's largest carrier, were ongoing.
"Shogun" star and producer Hiroyuki Sanada explains how his embattled Yoshii Toranaga masterfully manuevered in the acclaimed FX series' finale.
A rally attempt is underway. Tesla and AI play Vertiv were big earnings winners. Meta and ServiceNow loom tonight.
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of KRAS-mutated cancers. HOOKIPA’s HB-700 program is designed
I’ve previously exhibited a total lack of interest in gardening, but this is the year when everything will change
According to a recent analysis of retirement expenses on GOBankingRates, the amount of money you'll need for retirement will vary greatly depending on what state you choose to live in. It can cost you...
Enacted in 1935, Social Security has been one of the most successful programs in U.S. history. Social Security was originally designed to help provide a backstop for Americans suffering from the...
Experts believe that phone-based childhoods are seriously harming mental health — and parents are fighting back, says Emily Phillips
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today announced the successful trial deployment of Arqit’s Network Secure product by the Satellite Applications Catapult which works across the space sector to make use of and benefit from satellite technologies. The satellite sector is strategically important with long lived sensitive data and so is a prime target for intellectual property theft. Satellite sector org
DUBLIN, April 24, 2024--CRH plc, the leading provider of building materials solutions, will publish its Q1 2024 financial results on Friday, May 10, 2024 at 2:00 a.m. (New York) / 7:00 a.m. (Dublin) followed by a conference call and webcast presentation at 8:00 a.m. (New York) / 1:00 p.m. (Dublin). CRH's results and the related presentation will be available at www.crh.com/investors/results-presentations.
TORONTO, April 24, 2024--In a time marked by increasing digital threats, such as suspicious texts or questionable emails, online security is more important than ever. Today, goConfirm, a trailblazer in portable digital identity solutions, proudly announces the launch of its latest innovation: ScamSpotter by goConfirm, an AI powered solution designed to analyze all forms of digital communication to assist consumers in identifying scams before they cause harm.
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Wednesday, May 1, 2024 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business overview. To access the live conference call, please dial (646)
July 5, 2024 payment date following June 10, 2024 record dateTORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“Rogers”) announced that its Board of Directors declared a quarterly dividend totaling 50 cents per share (the “Quarterly Dividend”) on each of its outstanding Class B Non-Voting shares (“Class B Shares”) and Class A Voting shares. The Quarterly Dividend will be paid on July 5, 2024 to shareholders of record on June 10, 2024. Quar
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report its first quarter 2024 financial results and provide a business update on May 9, 2024, at 7:00 am Eastern Time. Investors who would like to discuss the financial results or business update after the earnings release has been
Yahoo Finance 